Memory and Aging Center Grand Rounds

“Expanding Mechanisms and Therapeutic Targets for Neurodegenerative Disease”

Aaron Gitler, PhD
Professor, Genetics
Stanford University



Attendees will:

  • Learn the role of RNA-binding proteins, including TDP-43, in the neurodegenerative disease ALS;
  • Learn strategies to identify disease modifier genes for neurodegenerative diseases like ALS;
  • Learn mechanisms by which C9orf72 mutations cause ALS and FTD;
  • Learn experimental approaches to studying neurodegenerative disease mechanisms, including the use of model systems and genome-wide screens.


  • Planners: Charles Windon, MD; Bruce L. Miller, MD; Howard J. Rosen, MD; and Eleanor O’Brien have stated they have no relationships to disclose.
  • Speaker: Dr. Gitler has no relevant relationships to disclose.

Accreditation: The University of California, San Francisco (UCSF) School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation: UCSF designates this live activity for a maximum of 22 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The above credit is inclusive of all Memory and Aging Center Grand Rounds sessions offered July 2019 through December 2019. (1 credit per each 1-hour grand rounds session throughout the year).

NOTE: You must sign in to qualify for CME Credit

Grand Rounds presentations are for educational purposes and intended for a professional audience. This activity is not commercially supported.

Friday, July 19, 2019 at 8:00am to 9:00am

Rock Hall, Pottruck Auditorium, RH 102
1550 4th Street, San Francisco, CA 94158

Event Type

Grand Rounds


School of Medicine


Students, Postdocs, Faculty, Staff


Mission Bay


Memory and Aging Center, Department of Neurology, UCSF Weill Institute for Neurosciences


Contact Info


Recent Activity